News

Hosted on MSN7mon
Trimetallic-based nanocarriers method shows promise for visualized idiopathic pulmonary fibrosis therapy
A research group from Ningbo Institute of Materials Technology and Engineering (NIMTE) of the Chinese Academy of Sciences (CAS) developed a novel method for idiopathic pulmonary fibrosis (IPF ...
Hosted on MSN1mon
Dry cough and shortness of breath persistent idiopathic pulmonary fibrosis, average survival time of only 3-5 years
Although the domestic prevalence of idiopathic ... resolution chest CT (computerized tomography) because it is difficult to accurately discriminate idiopathic pulmonary fibrosis by chest X-rays ...
University of Sheffield1y
Pulmonary imaging
Our research focus is the application of magnetic resonance imaging (MRI) techniques to pulmonary diseases ... ∆VVF = change in ventilated volume fraction. CT images (top) and helium-3 (3He) diffusion ...
Nature1mon
First drug for idiopathic pulmonary fibrosis approved in Japan
Shionogi and InterMune have announced the marketing approval of pirfenidone (Pirespa) for the treatment of idiopathic pulmonary fibrosis (IPF) in Japan, making it the first approved therapy for ...